Stress Urinary Incontinence in Elite Athletes

University of Trás-os-Montes and Alto Douro

Status: Unknown

Conditions: Pelvic Floor Disorders

Treatments: Behavioral: Pelvic Floor Muscle Training (PFMT); Diagnostic Test: Pad test

Study type: Interventional

Funder types: Other

Identifiers

NCT03938779

25/2017

Details and patient eligibility

About

A protocol of pelvic floor muscles training (PFMT) in elite athletes was applied. They will do it for 4 months. Then re-evaluated.

Full description

The athletes of the Portuguese national female's volleyball team were evaluated through perineometry, pad-test and Kings health questionnaire. They were taught a plan of pelvic floor muscles training (PFMT) to perform for 4 months. After this time they will be re-evaluated with the same measuring instruments.

Enrollment: 15 estimated patients

Sex: Female

Ages: 15 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Elite female athletes
• Nulliparous
• Volleyball team.

Exclusion criteria

• Inability to contract the PFM, elderly
• Prolapse of the pelvic organs.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

15 participants in 4 patient groups

Pelvic Floor Muscle Training (PFMT)

Experimental group

Description:

Experimental group will perform for 4 months a PFMT

Treatment:

Behavioral: Pelvic Floor Muscle Training (PFMT)

Pad test

Experimental group

Description:

The experimental and control group will perform the pad test twice. At the beginning of the evaluation and 4 months after the PFMT. The modified pad test, has the durability of a workout (2h30min)

Treatment:

Diagnostic Test: Pad test

Kings Health Questionnaire

No Intervention group

Description:

Kings Health Questionnaire to assess the impact of urinary incontinence on quality of life of women. Both groups will complete the questionnaire.

perineometer

No Intervention group

Description:

Both groups will perform perineometry at baseline and 4 months after